[Cutaneous lymphoma in Tunisia: clinical profile and therapeutic results]

Cancer Radiother. 1998 Jul-Aug;2(4):404-7. doi: 10.1016/S1278-3218(98)80353-3.
[Article in French]

Abstract

Purpose: The aim of this retrospective study was to investigate therapeutic result of cutaneous lymphoma in Tunisia.

Patients and methods: Between January 1969 and June 1994, 100 patients with cutaneous lymphoma were referred either to Salah Azaiz Institute or the other University Hospitals of Tunisia. Fifty-one patients had epidermotropic lymphoma and 49 non-epidermotropic lesions. Eighty-seven patients received complete treatment. Puvatherapy and other local dermatologic treatments were used for early stage mycosis fungoïdes. Thirty-two patients benefited from radiotherapy, with curative dose in 28 cases. Chemotherapy including anthracyclin agents was used for high grade lymphoma. Thirteen patients had association of radiotherapy and chemotherapy.

Results: Five-year survival rates were 50% for patients with epidermotropic lesions and 56% for patients with non-epidermotropic cutaneous lymphoma. Statistical study has not identified any significant prognosis factor.

Conclusion: Radiotherapy and chemotherapy are both effective. Treatment should depend on stage and histologic type.

Publication types

  • English Abstract
  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • Humans
  • Lymphoma / drug therapy*
  • Lymphoma / radiotherapy*
  • Lymphoma, Non-Hodgkin / drug therapy
  • Lymphoma, Non-Hodgkin / radiotherapy
  • Male
  • Middle Aged
  • Mycosis Fungoides / drug therapy
  • Mycosis Fungoides / radiotherapy
  • Prednisone / administration & dosage
  • Prognosis
  • Retrospective Studies
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / radiotherapy*
  • Survival Analysis
  • Tunisia
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • CHOP protocol